TP53 and cancer: However, E6's oncogenic activities cannot be explained solely by its effects on p53, and mutants deficient for degradation of p53 can still immortalize mammary epithelial cells, suggesting that interactions with cellular factors other than p53 are necessary for cancer development [11].